ESSILORLUXOTTICA USA INC.

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$1.6M

Filings

Firms Hired

Active Period

2024–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$630,000	3	1
2025	$560,000	4	1
2024	$410,000	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
ESSILORLUXOTTICA USA INC.	$1,600,000	11

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	10
SENATE	10
Homeland Security, Dept of (DHS)	2
Intl Trade Administration (ITA)	2
Government Accountability Office (GAO)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	11
Budget/Appropriations	Budget/Appropriations	1
Tariff (miscellaneous tariff bills)	Tariff (miscellaneous tariff bills)	1

Bills Explicitly Cited (22)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1521119th Congress

DOC Access Act of 2025

2026 · third_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; Issues related to Myopia education; Labor, Health and Human Services appropriations; H.R.1521 - DOC Access Act; S.1716 - Vision Lab Choice Act.

Client expense: $300,000 · Firm income: —

Matched citations: H.R.1521

S. 1716119th Congress

Vision Lab Choice Act of 2025

2026 · third_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; Issues related to Myopia education; Labor, Health and Human Services appropriations; H.R.1521 - DOC Access Act; S.1716 - Vision Lab Choice Act.

Client expense: $300,000 · Firm income: —

Matched citations: S.1716

H.R. 1521119th Congress

DOC Access Act of 2025

2026 · second_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; Issues related to Myopia education; Labor, Health and Human Services appropriations; Tariffs; US-Mexico-Canada Trade Agreement; H.R.1521 - DOC Access Act; S.1716 - Vision Lab Choice Act.

Client expense: $180,000 · Firm income: —

Matched citations: H.R.1521

S. 1716119th Congress

Vision Lab Choice Act of 2025

2026 · second_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; Issues related to Myopia education; Labor, Health and Human Services appropriations; Tariffs; US-Mexico-Canada Trade Agreement; H.R.1521 - DOC Access Act; S.1716 - Vision Lab Choice Act.

Client expense: $180,000 · Firm income: —

Matched citations: S.1716

Show 18 more cited filings

H.R. 1521119th Congress

DOC Access Act of 2025

2026 · first_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; Issues related to Myopia education; Government Accountability Office Report; Tariffs; US-Mexico-Canada Trade Agreement; H.R.1521 - DOC Access Act; S.1716 - Vision Lab Choice Act.

Client expense: $150,000 · Firm income: —

Matched citations: H.R.1521

S. 1716119th Congress

Vision Lab Choice Act of 2025

2026 · first_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; Issues related to Myopia education; Government Accountability Office Report; Tariffs; US-Mexico-Canada Trade Agreement; H.R.1521 - DOC Access Act; S.1716 - Vision Lab Choice Act.

Client expense: $150,000 · Firm income: —

Matched citations: S.1716

H.R. 1521119th Congress

DOC Access Act of 2025

2025 · fourth_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act; Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act; S. 1716, Vision Lab Choice Act.

Client expense: $150,000 · Firm income: —

Matched citations: H.R. 1521

H.R. 2853119th Congress

Combating Organized Retail Crime Act of 2025

2025 · fourth_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act; Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act; S. 1716, Vision Lab Choice Act.

Client expense: $150,000 · Firm income: —

Matched citations: H.R. 2853

S. 1404119th Congress

Combating Organized Retail Crime Act

2025 · fourth_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act; Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act; S. 1716, Vision Lab Choice Act.

Client expense: $150,000 · Firm income: —

Matched citations: S. 1404

S. 1716119th Congress

Vision Lab Choice Act of 2025

2025 · fourth_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act; Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act; S. 1716, Vision Lab Choice Act.

Client expense: $150,000 · Firm income: —

Matched citations: S. 1716

H.R. 1521119th Congress

DOC Access Act of 2025

2025 · third_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act; Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act; S. 1716, Vision Lab Choice Act.

Client expense: $130,000 · Firm income: —

Matched citations: H.R. 1521

H.R. 2853119th Congress

Combating Organized Retail Crime Act of 2025

2025 · third_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act; Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act; S. 1716, Vision Lab Choice Act.

Client expense: $130,000 · Firm income: —

Matched citations: H.R. 2853

S. 1404119th Congress

Combating Organized Retail Crime Act

2025 · third_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act; Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act; S. 1716, Vision Lab Choice Act.

Client expense: $130,000 · Firm income: —

Matched citations: S. 1404

S. 1716119th Congress

Vision Lab Choice Act of 2025

2025 · third_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act; Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act; S. 1716, Vision Lab Choice Act.

Client expense: $130,000 · Firm income: —

Matched citations: S. 1716

H.R. 1521119th Congress

DOC Access Act of 2025

2025 · second_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act (CORCA); Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act

Client expense: $150,000 · Firm income: —

Matched citations: H.R. 1521

H.R. 2853119th Congress

Combating Organized Retail Crime Act of 2025

2025 · second_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act (CORCA); Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act

Client expense: $150,000 · Firm income: —

Matched citations: H.R. 2853

S. 1404119th Congress

Combating Organized Retail Crime Act

2025 · second_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act (CORCA); Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act

Client expense: $150,000 · Firm income: —

Matched citations: S. 1404

H.R. 895118th Congress

Combating Organized Retail Crime Act of 2023

2024 · fourth_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; Expanding telehealth flexibilities in Medicare; H.R. 895 / S. 140, Combating Organized Retail Crime Act (CORCA); Energy and Commerce Committee letter to Government Accountability Office

Client expense: $130,000 · Firm income: —

Matched citations: H.R. 895

S. 140118th Congress

Combating Organized Retail Crime Act of 2023

2024 · fourth_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

Introduction to EssilorLuxottica; Med-tech innovations; Expanding telehealth flexibilities in Medicare; H.R. 895 / S. 140, Combating Organized Retail Crime Act (CORCA); Energy and Commerce Committee letter to Government Accountability Office

Client expense: $130,000 · Firm income: —

Matched citations: S. 140

H.R. 1385118th Congress

DOC Access Act of 2023

2024 · second_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2748/S. 4083, The Contact Lens Prescription Verification Modernization Act; Issues related to Myopia education, need for comprehensive pediatric eye exams, establishment of an interagency taskforce on Myopia; Introduction to Nuance product and EssilorLuxottica; H.R. 1385, the Dental and Optometric Care Access Act; Energy and Commerce Committee letter to Government Accountability Office

Client expense: $150,000 · Firm income: —

Matched citations: H.R. 1385

H.R. 2748118th Congress

Contact Lens Prescription Verification Modernization Act

2024 · second_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2748/S. 4083, The Contact Lens Prescription Verification Modernization Act; Issues related to Myopia education, need for comprehensive pediatric eye exams, establishment of an interagency taskforce on Myopia; Introduction to Nuance product and EssilorLuxottica; H.R. 1385, the Dental and Optometric Care Access Act; Energy and Commerce Committee letter to Government Accountability Office

Client expense: $150,000 · Firm income: —

Matched citations: H.R. 2748

S. 4083118th Congress

Contact Lens Prescription Verification Modernization Act

2024 · second_quarter · Firm: ESSILORLUXOTTICA USA INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2748/S. 4083, The Contact Lens Prescription Verification Modernization Act; Issues related to Myopia education, need for comprehensive pediatric eye exams, establishment of an interagency taskforce on Myopia; Introduction to Nuance product and EssilorLuxottica; H.R. 1385, the Dental and Optometric Care Access Act; Energy and Commerce Committee letter to Government Accountability Office

Client expense: $150,000 · Firm income: —

Matched citations: S. 4083

Source: Senate LDA

ESSILORLUXOTTICA USA INC. — Lobbying Disclosure | Poliscope